St Elevation Myocardial Infarction

Delaying or stopping STEMI treatment during the first COVID-19-related lockdown in England was associated with approximately 2 life-years lost per patient vs. pre-lockdown conditions, according to a modeling analysis presented at EuroPCR.

WASHINGTON — Sodium thiosulfate, administered before and after reperfusion for STEMI, did not improve infarct size between 4 months and 2 years compared with placebo, a speaker reported.

WASHINGTON — In patients with MI at high risk for stroke, implanting a loop recorder did not impact subsequent CV events, according to the results of the BIO | GUARD-MI trial.

WASHINGTON — New, 2-year data from a global registry enrolling patients with STEMI in low- and middle-income countries showed continued improvement in trends for key clinical and system parameters, including mortality, researchers reported.

Women are more likely to have an in-hospital vs. out-of-hospital STEMI, with women experiencing an average 10‐minute delay from symptom onset to reperfusion compared with men, according to an analysis of registry data.

Risk factors for patients with acute MI have changed modestly as treatment has improved, with mortality rates significantly declining for patients with non-STEMI and remaining stable for patients with STEMI.

In a new study, among low-risk patients who received primary PCI for STEMI, an early discharge pathway was shown to be both safely and successfully integrated.

Ticagrelor added to low-dose aspirin reduced the risk for spontaneous MI, MI related to stent thrombosis and STEMI compared with placebo in patients with diabetes and CAD, according to a new analysis of the THEMIS trial.

Reductions in air pollution were associated with lower rates of STEMI, a trend which manifested during the shutdowns at the beginning of the COVID-19 pandemic, according to data from the American Heart Association Scientific Sessions.

In a cohort of patients with STEMI, a COVID-19 diagnosis significantly increased the rates of in-hospital mortality compared with patients without a COVID-19 diagnosis from the past year, according to new data.